Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000282 · ClinicalTrials.gov registry record · Phase 2

Pemoline for Cocaine Abuse - 7

A Phase 2 study, sponsored by Yale University.

Completed
Registry status
Phase 2
Development phase

NCT00000282 is a Phase 2 study that has completed, run by Yale University.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000282, a Phase 2 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 2
Development phase

Study Summary

The purpose of this study is to evaluate the treatment of pemoline for cocaine abuse.

Interventions

  • DRUG Pemoline

Trial Details

FieldValue
Start Date 1994-09
Est. Completion 1999-08
Phase Phase 2

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT00000282

The ClinicalTrials.gov registry entry for NCT00000282 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pemoline is the first listed.

NCT00000282 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00000282 about?

NCT00000282 is a clinical study titled "Pemoline for Cocaine Abuse - 7". The purpose of this study is to evaluate the treatment of pemoline for cocaine abuse.

What is the current status of trial NCT00000282?

This trial is currently completed. It is a Phase 2 study. The study started on 1994-09. Estimated completion is 1999-08.

What interventions are being tested in trial NCT00000282?

The interventions under investigation include: Pemoline (DRUG).

Who is sponsoring clinical trial NCT00000282?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.